Literature DB >> 15761002

Validity of composite end points in clinical trials.

Victor M Montori1, Gaietà Permanyer-Miralda, Ignacio Ferreira-González, Jason W Busse, Valeria Pacheco-Huergo, Dianne Bryant, Jordi Alonso, Elie A Akl, Antònia Domingo-Salvany, Edward Mills, Ping Wu, Holger J Schünemann, Roman Jaeschke, Gordon H Guyatt.   

Abstract

Mesh：

Year:  2005        PMID： 15761002      PMCID： PMC554039          DOI： 10.1136/bmj.330.7491.594

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Composite outcomes in randomized trials: greater precision but with greater uncertainty?

Authors:  Nick Freemantle; Melanie Calvert; John Wood; Joanne Eastaugh; Carl Griffin
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators.

Authors:  D W Taylor; H J Barnett; R B Haynes; G G Ferguson; D L Sackett; K E Thorpe; D Simard; F L Silver; V Hachinski; G P Clagett; R Barnes; J D Spence
Journal:  Lancet       Date:  1999-06-26       Impact factor: 79.321

4.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.

Authors:  D E Niewoehner; M L Erbland; R H Deupree; D Collins; N J Gross; R W Light; P Anderson; N A Morgan
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

5.  Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.

Authors: 
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321
  7 in total
  88 in total

1.  Outcome measures in health research: from assessing validity to outcome reporting.

Authors:  Gianni Virgili; Laura Amato; Kristina Lindsley; Jennifer Evans
Journal:  Intern Emerg Med       Date:  2015-11-24       Impact factor: 3.397

Review 2.  Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.

Authors:  Jasim A Anabrees; Khalid M Aifaleh
Journal:  J Clin Neonatol       Date:  2012-01

Review 3.  Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

Authors:  Ignacio Ferreira-González; Jason W Busse; Diane Heels-Ansdell; Victor M Montori; Elie A Akl; Dianne M Bryant; Pablo Alonso-Coello; Jordi Alonso; Andrew Worster; Suneel Upadhye; Roman Jaeschke; Holger J Schünemann; Gaietà Permanyer-Miralda; Valeria Pacheco-Huergo; Antònia Domingo-Salvany; Ping Wu; Edward J Mills; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-02

4.  Composite and surrogate outcomes in randomised controlled trials.

Authors:  Nick Freemantle; Mel Calvert
Journal:  BMJ       Date:  2007-04-14

5.  Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Susan L Norris; Sam Schulman; Jack Hirsh; Mark H Eckman; Elie A Akl; Mark Crowther; Per Olav Vandvik; John W Eikelboom; Marian S McDonagh; Sandra Zelman Lewis; David D Gutterman; Deborah J Cook; Holger J Schünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 6.  Waking up from the DREAM of preventing diabetes with drugs.

Authors:  Victor M Montori; William L Isley; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-28

7.  Addressing the future role of general practice at the 16th Nordic Congress in Copenhagen 2009: how can we ensure sustainable care in a complex world of evidence, context, organization, and personal care?

Authors:  Susanne Reventlow; Henrik Sångren; John Brodersen; Bo Christensen; Anette Grauengaard; Dorte Jarbøl; Marianne Rosendal; Jens Søndergaard
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

Review 8.  Hospital mortality: when failure is not a good measure of success.

Authors:  Kaveh G Shojania; Alan J Forster
Journal:  CMAJ       Date:  2008-07-15       Impact factor: 8.262

Review 9.  Concordance of effects of medical interventions on hospital admission and readmission rates with effects on mortality.

Authors:  Lars G Hemkens; Despina G Contopoulos-Ioannidis; John P A Ioannidis
Journal:  CMAJ       Date:  2013-10-21       Impact factor: 8.262

Review 10.  Meaningful outcome measures in cardiac surgery.

Authors:  Paul S Myles
Journal:  J Extra Corpor Technol       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.